Capstone Extends Credit Facilities with Beacon Bank and Stream Finance on Identical Terms
June 22, 2026
INmune Bio, Inc. Receives Health Canada “No Objection Letter” to Commence Clinical Trial of XPro1595 in Mild Alzheimer’s Disease
November 14, 2022
Related Post
-
-
Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers
June 22, 2026
-
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
June 22, 2026
-
The AI Boom’s Real Bottleneck Is Power – and One Nasdaq Company Is Reinventing Itself to Solve It
June 18, 2026